| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.28 | 3e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.27 | 6e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |